These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1945605)

  • 1. Differences in antibody response to whole-cell pertussis vaccines.
    Edwards KM; Decker MD; Halsey NA; Koblin BA; Townsend T; Auerbach B; Karzon DT
    Pediatrics; 1991 Nov; 88(5):1019-23. PubMed ID: 1945605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
    Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
    Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y; Sato H
    Dev Biol Stand; 1991; 73():251-62. PubMed ID: 1778317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological responses to infection with B. pertussis.
    Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A
    Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial.
    Blennow M; Granström M; Jäätmaa E; Olin P
    Pediatrics; 1988 Sep; 82(3):293-9. PubMed ID: 3043367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
    Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
    Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
    [No Abstract]   [Full Text] [Related]  

  • 11. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
    Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
    Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acellular pertussis vaccines in infants: evaluation of single component and two-component products.
    Anderson EL; Mink CM; Berlin BS; Shih CN; Tung FF; Belshe RB
    Vaccine; 1994 Jan; 12(1):28-31. PubMed ID: 8303937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children.
    Pichichero ME; Green JL; Francis AB; Marsocci SM; Lynd AM; Litteer T
    Pediatr Infect Dis J; 1994 Mar; 13(3):193-6. PubMed ID: 8177626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new highly purified pertussis vaccine in infants and children.
    Edwards KM; Bradley RB; Decker MD; Palmer PS; Van Savage J; Taylor JC; Dupont WD; Hager CC; Wright PF
    J Infect Dis; 1989 Nov; 160(5):832-7. PubMed ID: 2809258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age.
    Aoyama T; Murase Y; Kato M; Iwai H; Iwata T
    Am J Dis Child; 1989 Jun; 143(6):655-9. PubMed ID: 2471406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.
    Halperin SA; Barreto L; Eastwood BJ; Law B; Roberts EA
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1220-4. PubMed ID: 7921131
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity and potency evaluation of pertussis vaccines.
    Corbel MJ; Xing DK
    Expert Rev Vaccines; 2004 Feb; 3(1):89-101. PubMed ID: 14761246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safer acellular and whole-cell pertussis vaccines.
    Cameron J
    Lancet; 1987 Jun; 1(8547):1427-8. PubMed ID: 2884511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.